期刊文献+

冠状动脉内应用替罗非班对急诊介入治疗急性心肌梗死患者心肌灌注的影响 被引量:1

Effect of intracoronary tirofiban on myocardial reperfusion in patients with STEMI undergoing percutaneous coronary intervention
下载PDF
导出
摘要 目的探讨急诊冠脉介入治疗(PCI)术中冠脉内应用替罗非班对急性心肌梗死(AMI)患者冠脉血流的影响。方法接受急诊PCI治疗的急性ST段抬高型心肌梗死(STEMI)患者114例随机分为替罗非班组及对照组。替罗非班组(n=58)冠状动脉内注射替罗非班10μg/kg,继之以0.075 ug/(kg.min)静脉滴注24~48 h,对照组(n=56)不应用替罗非班。比较两组患者PCI术后90 min心电图ST段回落百分比(sum STR),根据冠状动脉造影图像观察两组患者TIMI血流分级情况。结果替罗非班组TIMI3级血流比例显著高于对照组,差异有统计学意义(77.6%比48.2%,P<0.01)。替罗非班组ST段回落程度明显优于对照组,差异有统计学意义(P<0.05)。结论急诊PCI的STEMI患者冠脉内注射替罗非班可显著改善靶血管前向血流TIMI分级,增加心肌组织灌注。 Objective To explore the effect of intracoronary tirofiban on myocardial reperfusion in patients with acute myocardial infarction ( AMI )undergoing emergency percutaneous coronary intervention ( PCI ). Methods 114 patients with AMI treated by emer- gency percutaneous coronary intervention (PCI ) were selected and divided randomly into tirofiban group and control group, tirofiban group ( n = 58,10 p,g/kg bolus followed by 0. 075 μg/( kg · min ) infusion fou 24 to 48 hours ) , control group ( n = 56, no tirofihan ). The resolution of the sum of ST-segment elevation ( sum STR) 90 minutes after the procedure was compared between the two groups. Thrombolysis in myocardial infarction (TIMI) flow grade was assessed from coronary angiography picture at the end of PCI. Result Compared with control group, TIMI3 flow degree of tirofiban group in the last coronary angiography picture after PCI was significantly higher (77. 6% vs 48.2% ,P 〈 0. 01 ). The sum STR in tirofiban group at 90 minutes after the procedure was higher than control group ( P 〈 0.05 ). Conclusion Intracoronary injections of tirofiban to STEMI patients during emergency PCI could improve acoronary arteri- al blood flow and myocardial tissue perfusion.
出处 《滨州医学院学报》 2013年第2期102-104,共3页 Journal of Binzhou Medical University
基金 山东省高等学校科技计划项目(No.J11LF98)
关键词 替罗非班 心肌梗死 经皮冠状动脉介入治疗 Tirofiban, myocardial infarction, percutaneous coronary intervention
  • 相关文献

参考文献10

  • 1Skyschally A, Leineweber K, Gres P, et al. Coronary microemboliza-tion[J] Basic Res Cardiol,2006,101(5) :373-382.
  • 2Stone GW, Grines CL, Cox DA, et al. Comparision of angioplasty with stenting, with or without abciximab, in acute myocardial infarction [J]. N Eng J Med,2002,346(7) :957-966.
  • 3宋玉娥,王琳,李芳,龚培力,王朝晖,党瑜华.盐酸替罗非班对急性冠状动脉综合征的疗效和安全性评价[J].临床心血管病杂志,2006,22(4):220-222. 被引量:71
  • 4Wtihrle J, Nusser T, Mayer C, et al. Intracoronary application of ab- ciximab in patients with ST-elevation myocardial infarction[ J]. Euro Intervention,2008, 3 (4) :465-469.
  • 5Deibele A J, Jennings LK, Tcheng JE,et al. Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa recepor occupancy and platelet function: The Intracoronary Eptifibatide (ICE) Trial[ J ]. Circulation,2010,121 ( 6 ) :784-791.
  • 6Sezer M, Cimen A, Aslanger E, et al. Effect of intracoronary strepto- kinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function[ J]. J Am Coil Cardiol (Engl) ,2009,54(12) : 1065-1071.
  • 7Wu TG, Zhao Q, Huang WG, et al. Effect of intracoronary tirofiban in patients undergoing percutaneous for acute coronary intervention cor- onary syndrome[ J]. Circ J,2008,72(10) 1605-1609.
  • 8唐强,霍勇,陈明,李建平,洪涛,郭来敬,王智,张树和,曲华清.盐酸替罗非班对急性心肌梗死急诊经皮冠状动脉介入治疗中TIMI血流影响的临床研究[J].中国介入心脏病学杂志,2006,14(2):97-99. 被引量:86
  • 9Alexander D, Mann N, Ou FS, et al. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for a- cute ST-elevation myocardial infarction (from the CRUSADE Nation- al Quality Improvement Initiative ) [ J]. Am J Cardiol, 2008, 102 ( 11 ) :1335-1340.
  • 10Erdim R, Erciye D. Gsrmez S, et al. Comparison of intracoronary versus intravenous administration of tirofiban in primary percutane- ous coronary intervention [ J ]. Anadolu Kardiyol Derg, 2010, 10 (4) : 340 -345.

二级参考文献11

  • 1STONE G W, MOLITERNO D J, BERTRAND M,et al. Impact of clinical syndrome acuity on the differential response to 2 glycoprotein Ⅱb/Ⅲa in hibitors inpatients undergoing coronary stenting the TARGET trial[J]. Circulation, 2002,105 :2345- 2354.
  • 2CROUCH M A, NAPPI J M, CHEANG K I. Glycoprotein Ⅱb/Ⅲa receptor inbibitors in percutan coronary intervention and acute coronary syndrome [J].Ann Pharmacother, 2003, 37: 860-875.
  • 3FUSTER V, BADIMON L, BADIMON J J, et al.The pathogenesis of coronary artery disease and the acute coronary syndromes [J]. N Engl J Med, 1992,326: 242- 250.
  • 4The Restore Investigators. Effects of platelet Glycoprotein Ⅱb/Ⅲa Blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty[J]. Circulation ,1997, 96: 1445-1453.
  • 5The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators.Inhibition of the platelet glycoprotein Ⅱb/Ⅲ a receptor with tirofiban in unstable angina and non-Q-wave rnyocardial infarction[J]. N Engl J Med, 1998, 338:1488-1497.
  • 6BOERSMA E, HARRINGTON R A, MOLITERNO D J, et al. Platelet glycoprotein Ⅱb/Ⅲa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials[J]. Lancet, 2002, 359:189-198.
  • 7TCHENG J E, ELLIS S G, GEORGE B S, et al.Pharmacodynamics of chimetic glycoprotein Ⅱb/Ⅲa integrin antiplatelet antibody Fab TEs in high-risk coronary angioplasty[J]. Circulation, 1994, 90:1757-1764.
  • 8Lefkovitz J,Plow EF,Topol EJ.Platelet glycoprotein Ⅱb/Ⅲa receptor in cardiovascular medicine.N Engl J Med,1995,332:1553-1558.
  • 9Montalescot G,Barragan P,Wittenbery O,et al.For the ADMIRAL investigators.Platelet glycopretion Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction.N Eng J Med,2001,21:1895-1903.
  • 10Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glycoprotein Ⅱb/Ⅲa inhibition with tirofiban before primary angioplasty improves angiographic outcome:Results of the Tirofiban give in the Emergency Room before primary angioplasty (TIGER-PA) pilot trial.Circulation,2003,107:1497-1501.

共引文献154

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部